
    
      After taking proper informed consent from patients, patients who fulfill the research
      criteria are randomized into 2 groups (control/study). Patients in both groups will be
      treated with conventional interferon alfa and Ribavirin.Those in study group will be given
      tab nitazoxanide 500mg twice daily in addition to conventional treatment. The patients will
      be followed up at regular intervals: 0,4,12,24,48 week.At each visit Hepatitis C
      Virus(PCR)RNA, Liver function tests, complete blood count will be done.
    
  